You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

DURABOLIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Durabolin, and when can generic versions of Durabolin launch?

Durabolin is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in DURABOLIN is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DURABOLIN?
  • What are the global sales for DURABOLIN?
  • What is Average Wholesale Price for DURABOLIN?
Summary for DURABOLIN
Drug patent expirations by year for DURABOLIN
Recent Clinical Trials for DURABOLIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Morten Tange Kristensen PT, PhDPhase 2
University Hospital OstravaN/A

See all DURABOLIN clinical trials

US Patents and Regulatory Information for DURABOLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc DURABOLIN nandrolone phenpropionate INJECTABLE;INJECTION 011891-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Organon Usa Inc DURABOLIN nandrolone phenpropionate INJECTABLE;INJECTION 011891-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

DURABOLIN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Durabolin (Nandrolone Decanoate)

Overview of Durabolin

Durabolin, also known as Nandrolone Decanoate, is a type of anabolic steroid that is converted in the body to testosterone and other sex hormones. It is widely used for its ability to increase muscle mass, improve athletic performance, and treat various medical conditions such as anemia and osteoporosis[4].

Market Size and Growth

The market for Nandrolone Decanoate is substantial and growing. As of 2023, the market size was valued at USD 100 billion and is expected to reach USD 140.71 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5% from 2024 to 2031. This growth is driven by increasing demand from both the medical and sports industries[1].

Market Segmentation

The Nandrolone Decanoate market is segmented based on type and application.

By Type

  • Injectable Grade: This is the most common form of Nandrolone Decanoate, widely used in medical and sports contexts.
  • Pharmaceutical Grade: Used in the production of pharmaceutical products.
  • Research Grade: Utilized in scientific research and development[1].

By Application

  • Anabolic Steroids: For muscle building and performance enhancement.
  • Muscle Building: Popular among bodybuilders and athletes.
  • Hormone Therapy: Used to treat hormonal imbalances and related conditions.
  • Sports Medicine: To enhance athletic performance and aid in recovery[1].

Geographical Distribution

The market is geographically segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Each region has its own set of market dynamics influenced by local regulations, healthcare awareness, and fitness trends[1].

Key Drivers of Market Growth

Several factors are driving the growth of the Nandrolone Decanoate market:

Medicinal Uses

Nandrolone Decanoate is used to treat chronic illnesses such as anemia and osteoporosis, contributing significantly to its market demand[1].

Fitness and Sports Trends

The global trend of increased fitness consciousness and the desire for performance-enhancing medications are key drivers. Athletes and bodybuilders seek Nandrolone Decanoate for its muscle-building and performance-enhancing properties[1].

Pharmaceutical Advancements

Advancements in pharmaceutical technology, such as innovative formulations and drug delivery methods, have improved the efficacy and attractiveness of Nandrolone Decanoate[1].

Regulatory Support

Regulatory approvals and supportive healthcare policies further enhance market dynamics, facilitating the growth of the Nandrolone Decanoate market[1].

Financial Trajectory

The financial performance of companies involved in the Nandrolone Decanoate market is robust and promising.

Revenue Growth

Companies like Organon International, Pfizer Inc., and Gen-Shi Laboratories are experiencing significant revenue growth due to the increasing demand for Nandrolone Decanoate. The market value is expected to continue growing, driven by expanding applications and geographical reach[1].

Profit Margins

The profitability of these companies is also on the rise, with strong EBITDA margins. For instance, the EBITDA margins for some pharmaceutical companies have seen substantial increases, reflecting the financial health and growth potential of the sector[2].

Competitive Landscape

The competitive landscape is characterized by a mix of established and emerging players. Companies are focusing on market entry strategies, new product launches, collaborations, and acquisitions to stay competitive. Understanding the market share of leading players and their strategic moves is crucial for navigating this competitive environment[1].

Regulatory Environment

The regulatory environment plays a critical role in shaping the market dynamics of Nandrolone Decanoate. In the U.S., for example, Nandrolone Decanoate is a Schedule III controlled substance, and its use is banned by the World Anti-Doping Agency (WADA). Regulatory changes, such as those affecting generic drug approvals, can impact market entry and competition[3][4].

Side Effects and Safety Concerns

Despite its widespread use, Nandrolone Decanoate has several side effects, including infertility, behavioral changes, hair loss, and breast development in men. It can also lead to liver damage and heart disease. These safety concerns can influence market dynamics, particularly in terms of regulatory scrutiny and consumer awareness[4].

Industry Dynamics

The generic drug industry, which includes Nandrolone Decanoate, is characterized by specific dynamics. Generic drug prices tend to fall with the number of competitors, but they remain above long-run marginal costs until there are at least 8 competitors. This dynamic affects the profitability and entry strategies of companies in the market[3].

Key Takeaways

  • The Nandrolone Decanoate market is valued at USD 100 billion in 2023 and is expected to reach USD 140.71 billion by 2031.
  • The market is driven by medicinal uses, fitness and sports trends, pharmaceutical advancements, and regulatory support.
  • The financial trajectory of companies involved is robust, with growing revenues and profit margins.
  • The competitive landscape is dynamic, with both established and emerging players.
  • Regulatory and safety concerns play a significant role in shaping market dynamics.

FAQs

What are the primary uses of Nandrolone Decanoate?

Nandrolone Decanoate is used for muscle building, hormone therapy, treating conditions like anemia and osteoporosis, and enhancing athletic performance.

What is the expected market size of Nandrolone Decanoate by 2031?

The market size of Nandrolone Decanoate is expected to reach USD 140.71 billion by 2031.

What are the key drivers of the Nandrolone Decanoate market growth?

Key drivers include medicinal uses, fitness and sports trends, pharmaceutical advancements, and regulatory support.

What are the potential side effects of Nandrolone Decanoate?

Potential side effects include infertility, behavioral changes, hair loss, breast development in men, liver damage, and heart disease.

How does the regulatory environment impact the Nandrolone Decanoate market?

The regulatory environment, including classifications as a controlled substance and bans by WADA, influences market entry, competition, and consumer awareness.

Sources

  1. Market Research Intellect - Nandrolone Decanoate Market Size, Share, Trends, Analysis, 2031
  2. HDFC Securities - Cadila Healthcare - IC - HSIE
  3. Federal Trade Commission - Generic Drug Industry Dynamics
  4. WebMD - Durabolin - Uses, Side Effects, and More
  5. Sharekhan - Zydus Life Science - Stock Idea

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.